Keywords
Last Name
Institution

Joanna Fowler

TitlePROFESSOR
InstitutionMount Sinai
DepartmentPsychiatry
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Seo YJ, Muench L, Reid A, Chen J, Kang Y, Hooker JM, Volkow ND, Fowler JS, Kim SW. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain. Bioorg Med Chem Lett. 2013 Dec 15; 23(24):6700-5.
      View in: PubMed
    2. Kim SW, Hooker JM, Otto N, Win K, Muench L, Shea C, Carter P, King P, Reid AE, Volkow ND, Fowler JS. Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. Nucl Med Biol. 2013 Oct; 40(7):912-8.
      View in: PubMed
    3. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Klein N, Wong C, Swanson JM, Shumay E. Association between dopamine D4 receptor polymorphism and age related changes in brain glucose metabolism. PLoS One. 2013; 8(5):e63492.
      View in: PubMed
    4. Wang GJ, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, Logan J, Jayne M, Wong CT, Han H, Fowler JS, Zhu W, Swanson JM. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS One. 2013; 8(5):e63023.
      View in: PubMed
    5. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J, Maynard LJ, Wong CT. Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism. J Neurosci. 2013 Mar 6; 33(10):4527-35.
      View in: PubMed
    6. Biegon A, Alia-Klein N, Fowler JS. Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain. Front Pharmacol. 2012; 3:185.
      View in: PubMed
    7. Shumay E, Logan J, Volkow ND, Fowler JS. Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men. Epigenetics. 2012 Oct; 7(10):1151-60.
      View in: PubMed
    8. Volkow ND, Kim SW, Wang GJ, Alexoff D, Logan J, Muench L, Shea C, Telang F, Fowler JS, Wong C, Benveniste H, Tomasi D. Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain. Neuroimage. 2013 Jan 1; 64:277-83.
      View in: PubMed
    9. Logan J, Carruthers NI, Letavic MA, Sands S, Jiang X, Shea C, Muench L, Xu Y, Carter P, King P, Fowler JS. Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon. Psychopharmacology (Berl). 2012 Oct; 223(4):447-55.
      View in: PubMed
    10. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J, Benveniste H, Kim R, Thanos PK, Ferré S. Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci. 2012 May 9; 32(19):6711-7.
      View in: PubMed
    11. Shumay E, Fowler JS, Wang GJ, Logan J, Alia-Klein N, Goldstein RZ, Maloney T, Wong C, Volkow ND. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability. Transl Psychiatry. 2012; 2:e86.
      View in: PubMed
    12. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci. 2012 Jan 18; 32(3):841-9.
      View in: PubMed
    13. Kinsella K, Schlyer DJ, Fowler JS, Martinez RJ, Sobecky PA. Evaluation of positron emission tomography as a method to visualize subsurface microbial processes. J Hazard Mater. 2012 Apr 30; 213-214:498-501.
      View in: PubMed
    14. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci. 2012; 11:1-24.
      View in: PubMed
    15. Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol. 2012; 52:321-36.
      View in: PubMed
    16. Shumay E, Chen J, Fowler JS, Volkow ND. Genotype and ancestry modulate brain's DAT availability in healthy humans. PLoS One. 2011; 6(8):e22754.
      View in: PubMed
    17. Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2012 Sep; 17(9):918-25.
      View in: PubMed
    18. Volkow ND, Tomasi D, Wang GJ, Fowler JS, Telang F, Goldstein RZ, Alia-Klein N, Woicik P, Wong C, Logan J, Millard J, Alexoff D. Positive emotionality is associated with baseline metabolism in orbitofrontal cortex and in regions of the default network. Mol Psychiatry. 2011 Aug; 16(8):818-25.
      View in: PubMed
    19. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A. 2011 Sep 13; 108(37):15037-42.
      View in: PubMed
    20. Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, Shumay E, Wang R, Telang F, Biegon A, Wang GJ, Fowler JS, Tomasi D, Volkow ND, Goldstein RZ. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry. 2011 Mar; 68(3):283-94.
      View in: PubMed
    21. Wang GJ, Geliebter A, Volkow ND, Telang FW, Logan J, Jayne MC, Galanti K, Selig PA, Han H, Zhu W, Wong CT, Fowler JS. Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring). 2011 Aug; 19(8):1601-8.
      View in: PubMed
    22. Volkow ND, Tomasi D, Wang GJ, Fowler JS, Telang F, Goldstein RZ, Alia-Klein N, Wong C. Reduced metabolism in brain "control networks" following cocaine-cues exposure in female cocaine abusers. PLoS One. 2011; 6(2):e16573.
      View in: PubMed
    23. Volkow ND, Tomasi D, Wang GJ, Vaska P, Fowler JS, Telang F, Alexoff D, Logan J, Wong C. Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA. 2011 Feb 23; 305(8):808-13.
      View in: PubMed
    24. Gifford AN, Kuschel S, Shea C, Fowler JS. Polymer-supported organotin reagent for prosthetic group labeling of biological macromolecules with radioiodine. Bioconjug Chem. 2011 Mar 16; 22(3):406-12.
      View in: PubMed
    25. Volkow ND, Fowler JS, Wang GJ, Shumay E, Telang F, Thanos PK, Alexoff D. Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS One. 2010; 5(12):e15269.
      View in: PubMed
    26. Biegon A, Kim SW, Alexoff DL, Jayne M, Carter P, Hubbard B, King P, Logan J, Muench L, Pareto D, Schlyer D, Shea C, Telang F, Wang GJ, Xu Y, Fowler JS. Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole. Synapse. 2010 Nov; 64(11):801-7.
      View in: PubMed
    27. Alexoff DL, Dewey SL, Vaska P, Krishnamoorthy S, Ferrieri R, Schueller M, Schlyer DJ, Fowler JS. PET imaging of thin objects: measuring the effects of positron range and partial-volume averaging in the leaf of Nicotiana tabacum. Nucl Med Biol. 2011 Feb; 38(2):191-200.
      View in: PubMed
    28. Tomasi D, Volkow ND, Wang GJ, Wang R, Telang F, Caparelli EC, Wong C, Jayne M, Fowler JS. Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage. 2011 Feb 14; 54(4):3101-10.
      View in: PubMed
    29. Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, Fowler JS, Goldstein RZ, Klein N, Logan J, Wong C, Swanson JM. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry. 2011 Nov; 16(11):1147-54.
      View in: PubMed
    30. Logan J, Alexoff D, Fowler JS. The use of alternative forms of graphical analysis to balance bias and precision in PET images. J Cereb Blood Flow Metab. 2011 Feb; 31(2):535-46.
      View in: PubMed
    31. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays. 2010 Sep; 32(9):748-55.
      View in: PubMed
    32. Volkow ND, Wang GJ, Tomasi D, Telang F, Fowler JS, Pradhan K, Jayne M, Logan J, Goldstein RZ, Alia-Klein N, Wong C. Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers. PLoS One. 2010; 5(7):e11509.
      View in: PubMed
    33. Shumay E, Fowler JS, Volkow ND. Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity. PLoS One. 2010; 5(6):e11067.
      View in: PubMed
    34. Shumay E, Fowler JS. Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches. Epigenetics. 2010 May 16; 5(4):325-42.
      View in: PubMed
    35. Wang R, Wang GJ, Goldstein RZ, Caparelli EC, Volkow ND, Fowler JS, Tomasi D. Induced magnetic force in human heads exposed to 4 T MRI. J Magn Reson Imaging. 2010 Apr; 31(4):815-20.
      View in: PubMed
    36. Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons. Biol Psychiatry. 2010 Apr 15; 67(8):774-7.
      View in: PubMed
    37. Volkow ND, Tomasi D, Wang GJ, Fowler JS, Telang F, Wang R, Alexoff D, Logan J, Wong C, Pradhan K, Caparelli EC, Ma Y, Jayne M. Effects of low-field magnetic stimulation on brain glucose metabolism. Neuroimage. 2010 Jun; 51(2):623-8.
      View in: PubMed
    38. Benveniste H, Fowler JS, Rooney WD, Scharf BA, Backus WW, Izrailtyan I, Knudsen GM, Hasselbalch SG, Volkow ND. Cocaine is pharmacologically active in the nonhuman primate fetal brain. Proc Natl Acad Sci U S A. 2010 Jan 26; 107(4):1582-7.
      View in: PubMed
    39. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Jayne M, Ma Y, Pradhan K, Wong C, Swanson JM. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage. 2010 Feb 1; 49(3):2536-43.
      View in: PubMed
    40. Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, Burch D, Brand B, Free J, Asgharnejad M, Wang GJ, Telang F, Hubbard B, Jayne M, King P, Carter P, Carter S, Xu Y, Shea C, Muench L, Alexoff D, Shumay E, Schueller M, Warner D, Apelskog-Torres K. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. Neuropsychopharmacology. 2010 Feb; 35(3):623-31.
      View in: PubMed
    41. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009 Sep 9; 302(10):1084-91.
      View in: PubMed
    42. Tomasi D, Wang GJ, Wang R, Backus W, Geliebter A, Telang F, Jayne MC, Wong C, Fowler JS, Volkow ND. Association of body mass and brain activation during gastric distention: implications for obesity. PLoS One. 2009; 4(8):e6847.
      View in: PubMed
    43. Tomasi D, Volkow ND, Wang R, Telang F, Wang GJ, Chang L, Ernst T, Fowler JS. Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS One. 2009; 4(6):e6102.
      View in: PubMed
    44. Alia-Klein N, Goldstein RZ, Tomasi D, Woicik PA, Moeller SJ, Williams B, Craig IW, Telang F, Biegon A, Wang GJ, Fowler JS, Volkow ND. Neural mechanisms of anger regulation as a function of genetic risk for violence. Emotion. 2009 Jun; 9(3):385-96.
      View in: PubMed
    45. Riss PJ, Hooker JM, Alexoff D, Kim SW, Fowler JS, Rösch F. [(11)C]PR04.MZ, a promising DAT ligand for low concentration imaging: Synthesis, efficient (11)C-O-methylation and initial small animal PET studies. Bioorg Med Chem Lett. 2009 Aug 1; 19(15):4343-5.
      View in: PubMed
    46. Kim SW, Biegon A, Katsamanis ZE, Ehrlich CW, Hooker JM, Shea C, Muench L, Xu Y, King P, Carter P, Alexoff DL, Fowler JS. Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase. Nucl Med Biol. 2009 Apr; 36(3):323-34.
      View in: PubMed
    47. Reid AE, Hooker J, Shumay E, Logan J, Shea C, Kim SW, Collins S, Xu Y, Volkow N, Fowler JS. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain. Nucl Med Biol. 2009 Apr; 36(3):247-58.
      View in: PubMed
    48. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA. 2009 Mar 18; 301(11):1148-54.
      View in: PubMed
    49. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med. 2009 Mar; 3(1):8-18.
      View in: PubMed
    50. Kil KE, Biegon A, Ding YS, Fischer A, Ferrieri RA, Kim SW, Pareto D, Schueller MJ, Fowler JS. Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug. Nucl Med Biol. 2009 Feb; 36(2):215-23.
      View in: PubMed
    51. Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, Zhu W, Wong CT, Thanos PK, Geliebter A, Biegon A, Fowler JS. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1249-54.
      View in: PubMed
    52. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Wang RL, Logan J, Wong C, Jayne M, Swanson JM. Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage. 2009 May 1; 45(4):1232-40.
      View in: PubMed
    53. Hooker JM, Reibel AT, Hill SM, Schueller MJ, Fowler JS. One-pot, direct incorporation of [11C]CO2 into carbamates. Angew Chem Int Ed Engl. 2009; 48(19):3482-5.
      View in: PubMed
    54. Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, Wong C, Thanos PK, Ma Y, Pradhan K. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring). 2009 Jan; 17(1):60-5.
      View in: PubMed
    55. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12; 363(1507):3191-200.
      View in: PubMed
    56. Goldstein RZ, Woicik PA, Moeller SJ, Telang F, Jayne M, Wong C, Wang GJ, Fowler JS, Volkow ND. Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire. J Psychopharmacol. 2010 Feb; 24(2):257-66.
      View in: PubMed
    57. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Wong C, Ma J, Pradhan K, Tomasi D, Thanos PK, Ferré S, Jayne M. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci. 2008 Aug 20; 28(34):8454-61.
      View in: PubMed
    58. Alia-Klein N, Kriplani A, Pradhan K, Ma JY, Logan J, Williams B, Craig IW, Telang F, Tomasi D, Goldstein RZ, Wang GJ, Volkow ND, Fowler JS. The MAO-A genotype does not modulate resting brain metabolism in adults. Psychiatry Res. 2008 Oct 30; 164(1):73-6.
      View in: PubMed
    59. Fowler JS, Volkow ND, Logan J, Alexoff D, Telang F, Wang GJ, Wong C, Ma Y, Kriplani A, Pradhan K, Schlyer D, Jayne M, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog K. Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine. Neuroimage. 2008 Dec; 43(4):756-63.
      View in: PubMed
    60. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage. 2008 Oct 1; 42(4):1537-43.
      View in: PubMed
    61. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009; 56 Suppl 1:3-8.
      View in: PubMed
    62. Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage. 2008 Aug 15; 42(2):869-78.
      View in: PubMed
    63. Tomasi D, Wang RL, Telang F, Boronikolas V, Jayne MC, Wang GJ, Fowler JS, Volkow ND. Impairment of attentional networks after 1 night of sleep deprivation. Cereb Cortex. 2009 Jan; 19(1):233-40.
      View in: PubMed
    64. Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, Tomasi D, Williams B, Telang F, Shumay E, Biegon A, Craig IW, Henn F, Wang GJ, Volkow ND, Fowler JS. Brain monoamine oxidase A activity predicts trait aggression. J Neurosci. 2008 May 7; 28(19):5099-104.
      View in: PubMed
    65. Baler RD, Volkow ND, Fowler JS, Benveniste H. Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders? J Psychiatry Neurosci. 2008 May; 33(3):187-95.
      View in: PubMed
    66. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Wong C, Ma J, Pradhan K, Benveniste H, Swanson JM. Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One. 2008; 3(4):e2017.
      View in: PubMed
    67. Reid AE, Ding YS, Eckelman WC, Logan J, Alexoff D, Shea C, Xu Y, Fowler JS. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. Nucl Med Biol. 2008 Apr; 35(3):287-98.
      View in: PubMed
    68. Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, Fowler JS. Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. Neuroimage. 2008 Jul 1; 41(3):1044-50.
      View in: PubMed
    69. Volkow ND, Ma Y, Zhu W, Fowler JS, Li J, Rao M, Mueller K, Pradhan K, Wong C, Wang GJ. Moderate doses of alcohol disrupt the functional organization of the human brain. Psychiatry Res. 2008 Apr 15; 162(3):205-13.
      View in: PubMed
    70. Hooker JM, Schönberger M, Schieferstein H, Fowler JS. A simple, rapid method for the preparation of [11C]formaldehyde. Angew Chem Int Ed Engl. 2008; 47(32):5989-92.
      View in: PubMed
    71. Wang GJ, Tomasi D, Backus W, Wang R, Telang F, Geliebter A, Korner J, Bauman A, Fowler JS, Thanos PK, Volkow ND. Gastric distention activates satiety circuitry in the human brain. Neuroimage. 2008 Feb 15; 39(4):1824-31.
      View in: PubMed
    72. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Jayne M, Ma Y, Pradhan K, Wong C. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci. 2007 Nov 14; 27(46):12700-6.
      View in: PubMed
    73. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007 Nov; 64(11):1575-9.
      View in: PubMed
    74. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage. 2008 Feb 1; 39(3):1266-73.
      View in: PubMed
    75. Fowler JS, Kroll C, Ferrieri R, Alexoff D, Logan J, Dewey SL, Schiffer W, Schlyer D, Carter P, King P, Shea C, Xu Y, Muench L, Benveniste H, Vaska P, Volkow ND. PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine. J Nucl Med. 2007 Oct; 48(10):1724-32.
      View in: PubMed
    76. Alia-Klein N, Goldstein RZ, Tomasi D, Zhang L, Fagin-Jones S, Telang F, Wang GJ, Fowler JS, Volkow ND. What is in a word? No versus Yes differentially engage the lateral orbitofrontal cortex. Emotion. 2007 Aug; 7(3):649-59.
      View in: PubMed
    77. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007 Aug; 64(8):932-40.
      View in: PubMed
    78. Kim SW, Ding YS, Alexoff D, Patel V, Logan J, Lin KS, Shea C, Muench L, Xu Y, Carter P, King P, Constanzo JR, Ciaccio JA, Fowler JS. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug. Nucl Med Biol. 2007 Jul; 34(5):541-51.
      View in: PubMed
    79. Logan J, Wang GJ, Telang F, Fowler JS, Alexoff D, Zabroski J, Jayne M, Hubbard B, King P, Carter P, Shea C, Xu Y, Muench L, Schlyer D, Learned-Coughlin S, Cosson V, Volkow ND, Ding YS. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol. 2007 Aug; 34(6):667-79.
      View in: PubMed
    80. Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect. 2007 Apr; 3(2):4-16.
      View in: PubMed
    81. Kil KE, Ding YS, Lin KS, Alexoff D, Kim SW, Shea C, Xu Y, Muench L, Fowler JS. Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). Nucl Med Biol. 2007 Feb; 34(2):153-63.
      View in: PubMed
    82. Volkow ND, Wang GJ, Fowler JS, Telang F, Jayne M, Wong C. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry. 2007 Jan; 164(1):157-60.
      View in: PubMed
    83. Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, Zhu W, Craig IW, Telang F, Goldstein R, Volkow ND, Vaska P, Wang GJ. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry. 2007 Aug 15; 62(4):355-8.
      View in: PubMed
    84. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K, Pradhan K. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage. 2007 Feb 1; 34(3):1182-90.
      View in: PubMed
    85. Du C, Yu M, Volkow ND, Koretsky AP, Fowler JS, Benveniste H. Cocaine increases the intracellular calcium concentration in brain independently of its cerebrovascular effects. J Neurosci. 2006 Nov 8; 26(45):11522-31.
      View in: PubMed
    86. Wang GJ, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, Wong CT, Tomasi D, Thanos PK, Fowler JS. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A. 2006 Oct 17; 103(42):15641-5.
      View in: PubMed
    87. Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry. 2006 Sep; 63(9):999-1008.
      View in: PubMed
    88. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci. 2006 Jun 14; 26(24):6583-8.
      View in: PubMed
    89. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Jayne M, Telang F, Swanson JM. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage. 2006 Oct 1; 32(4):1782-92.
      View in: PubMed
    90. Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse. 2006 Mar 15; 59(4):243-51.
      View in: PubMed
    91. Fowler JS, Logan J, Volkow ND, Wang GJ. Translational neuroimaging: positron emission tomography studies of monoamine oxidase. Mol Imaging Biol. 2005 Nov-Dec; 7(6):377-87.
      View in: PubMed
    92. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Shea C, Garza V, Xu Y, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P. Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med. 2005 Sep; 46(9):1414-20.
      View in: PubMed
    93. Volkow ND, Wang GJ, Franceschi D, Fowler JS, Thanos PP, Maynard L, Gatley SJ, Wong C, Veech RL, Kunos G, Kai Li T. Low doses of alcohol substantially decrease glucose metabolism in the human brain. Neuroimage. 2006 Jan 1; 29(1):295-301.
      View in: PubMed
    94. Logan J, Fowler JS. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers. Nucl Med Biol. 2005 Jul; 32(5):521-9.
      View in: PubMed
    95. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS, Hitzemann R, Swanson JM, Kalivas P. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005 Apr 13; 25(15):3932-9.
      View in: PubMed
    96. Volkow ND, Wang GJ, Fowler JS, Learned-Coughlin S, Yang J, Logan J, Schlyer D, Gatley JS, Wong C, Zhu W, Pappas N, Schueller M, Jayne M, Carter P, Warner D, Ding YS, Shea C, Xu Y. The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects. Biol Psychiatry. 2005 Mar 15; 57(6):640-6.
      View in: PubMed
    97. Benveniste H, Fowler JS, Rooney W, Ding YS, Baumann AL, Moller DH, Du C, Backus W, Logan J, Carter P, Coplan JD, Biegon A, Rosenblum L, Scharf B, Gatley JS, Volkow ND. Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates. J Nucl Med. 2005 Feb; 46(2):312-20.
      View in: PubMed
    98. Goldstein RZ, Alia-Klein N, Leskovjan AC, Fowler JS, Wang GJ, Gur RC, Hitzemann R, Volkow ND. Anger and depression in cocaine addiction: association with the orbitofrontal cortex. Psychiatry Res. 2005 Jan 30; 138(1):13-22.
      View in: PubMed
    99. Volkow ND, Wang GJ, Fowler JS, Ding YS. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1; 57(11):1410-5.
      View in: PubMed
    100. Gatley SJ, Volkow ND, Wang GJ, Fowler JS, Logan J, Ding YS, Gerasimov M. PET imaging in clinical drug abuse research. Curr Pharm Des. 2005; 11(25):3203-19.
      View in: PubMed
    101. Ding YS, Fowler JS, Logan J, Wang GJ, Telang F, Garza V, Biegon A, Pareto D, Rooney W, Shea C, Alexoff D, Volkow ND, Vocci F. 6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter. Synapse. 2004 Sep 1; 53(3):184-9.
      View in: PubMed
    102. Ding YS, Gatley SJ, Thanos PK, Shea C, Garza V, Xu Y, Carter P, King P, Warner D, Taintor NB, Park DJ, Pyatt B, Fowler JS, Volkow ND. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Synapse. 2004 Sep 1; 53(3):168-75.
      View in: PubMed
    103. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain. 2004 Nov; 127(Pt 11):2452-8.
      View in: PubMed
    104. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004 Jul; 161(7):1173-80.
      View in: PubMed
    105. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004 Jun; 9(6):557-69.
      View in: PubMed
    106. Thanos PK, Taintor NB, Rivera SN, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R, Fowler JS, Gatley SJ, Wang GJ, Volkow ND. DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcohol Clin Exp Res. 2004 May; 28(5):720-8.
      View in: PubMed
    107. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Ding YS, Shea C, Garza V, Xu Y, Li Z, Alexoff D, Vaska P, Ferrieri R, Schlyer D, Zhu W, John Gatley S. Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans. Nucl Med Biol. 2004 Apr; 31(3):313-9.
      View in: PubMed
    108. Fowler JS, Volkow ND, Wang GJ, Ding YS. 2-deoxy-2-[18F]fluoro-D-glucose and alternative radiotracers for positron emission tomography imaging using the human brain as a model. Semin Nucl Med. 2004 Apr; 34(2):112-21.
      View in: PubMed
    109. Wang GJ, Volkow ND, Telang F, Jayne M, Ma J, Rao M, Zhu W, Wong CT, Pappas NR, Geliebter A, Fowler JS. Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage. 2004 Apr; 21(4):1790-7.
      View in: PubMed
    110. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry. 2004 Feb; 161(2):242-8.
      View in: PubMed
    111. Zhu W, Volkow ND, Ma Y, Fowler JS, Wang GJ. Relationship between ethanol-induced changes in brain regional metabolism and its motor, behavioural and cognitive effects. Alcohol Alcohol. 2004 Jan-Feb; 39(1):53-8.
      View in: PubMed
    112. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, Wang GJ, Fowler JS, Volkow ND. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia. 2004; 42(11):1447-58.
      View in: PubMed
    113. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis. 2004; 23(3):39-53.
      View in: PubMed
    114. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004; 47 Suppl 1:3-13.
      View in: PubMed
    115. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003 Dec 10; 23(36):11461-8.
      View in: PubMed
    116. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, Schlyer D, Gatley SJ, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P. Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11600-5.
      View in: PubMed
    117. Benveniste H, Fowler JS, Rooney WD, Moller DH, Backus WW, Warner DA, Carter P, King P, Scharf B, Alexoff DA, Ma Y, Vaska P, Schlyer D, Volkow ND. Maternal-fetal in vivo imaging: a combined PET and MRI study. J Nucl Med. 2003 Sep; 44(9):1522-30.
      View in: PubMed
    118. Fowler JS, Logan J, Wang GJ, Franceschi D, Volkow ND, Telang F, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, King P, Schlyer D, Gatley SJ, Ding YS, Warner D, Netusil N, Carter P, Jayne M, Alexoff D, Zhu W, Vaska P. Monoamine oxidase A imaging in peripheral organs in healthy human subjects. Synapse. 2003 Sep 1; 49(3):178-87.
      View in: PubMed
    119. Wang GJ, Volkow ND, Fowler JS, Franceschi D, Wong CT, Pappas NR, Netusil N, Zhu W, Felder C, Ma Y. Alcohol intoxication induces greater reductions in brain metabolism in male than in female subjects. Alcohol Clin Exp Res. 2003 Jun; 27(6):909-17.
      View in: PubMed
    120. Alexoff DL, Vaska P, Marsteller D, Gerasimov T, Li J, Logan J, Fowler JS, Taintor NB, Thanos PK, Volkow ND. Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med. 2003 May; 44(5):815-22.
      View in: PubMed
    121. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003 May; 111(10):1444-51.
      View in: PubMed
    122. Volkow ND, Fowler JS, Wang GJ. Positron emission tomography and single-photon emission computed tomography in substance abuse research. Semin Nucl Med. 2003 Apr; 33(2):114-28.
      View in: PubMed
    123. Schiffer WK, Azmoodeh M, Gerasimov M, Volkow ND, Fowler JS, Dewey SL. Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine. Synapse. 2003 Apr; 48(1):35-8.
      View in: PubMed
    124. Li Z, Ding YS, Gifford A, Fowler JS, Gatley JS. Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging. Bioconjug Chem. 2003 Mar-Apr; 14(2):287-94.
      View in: PubMed
    125. Volkow ND, Wang GJ, Maynard L, Jayne M, Fowler JS, Zhu W, Logan J, Gatley SJ, Ding YS, Wong C, Pappas N. Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord. 2003 Mar; 33(2):136-42.
      View in: PubMed
    126. Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl). 2003 Mar; 166(3):264-70.
      View in: PubMed
    127. Fowler JS, Ding YS, Volkow ND. Radiotracers for positron emission tomography imaging. Semin Nucl Med. 2003 Jan; 33(1):14-27.
      View in: PubMed
    128. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology. 2003 Jan; 24(1):75-82.
      View in: PubMed
    129. Volkow ND, Wang GJ, Maynard L, Fowler JS, Jayne B, Telang F, Logan J, Ding YS, Gatley SJ, Hitzemann R, Wong C, Pappas N. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res. 2002 Dec 30; 116(3):163-72.
      View in: PubMed
    130. Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, Depue RA, Gur RC. The orbitofrontal cortex in methamphetamine addiction: involvement in fear. Neuroreport. 2002 Dec 3; 13(17):2253-7.
      View in: PubMed
    131. Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol. 2002 Dec; 12(6):557-66.
      View in: PubMed
    132. Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N, Thanos P. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse. 2002 Nov; 46(2):79-82.
      View in: PubMed
    133. Logan J, Fowler JS, Ding YS, Franceschi D, Wang GJ, Volkow ND, Felder C, Alexoff D. Strategy for the formation of parametric images under conditions of low injected radioactivity applied to PET studies with the irreversible monoamine oxidase A tracers [11C]clorgyline and deuterium-substituted [11C]clorgyline. J Cereb Blood Flow Metab. 2002 Nov; 22(11):1367-76.
      View in: PubMed
    134. Thanos PK, Taintor NB, Alexoff D, Vaska P, Logan J, Grandy DK, Fang Y, Lee JH, Fowler JS, Volkow ND, Rubinstein M. In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET. J Nucl Med. 2002 Nov; 43(11):1570-7.
      View in: PubMed
    135. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002 Nov; 78(3):610-24.
      View in: PubMed
    136. Fowler JS, Logan J, Wang GJ, Volkow ND, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, MacGregor RR, Schlyer D, Gatley SJ, Ding YS, Alexoff D. PET imaging of monoamine oxidase B in peripheral organs in humans. J Nucl Med. 2002 Oct; 43(10):1331-8.
      View in: PubMed
    137. Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets. 2002 Oct; 6(5):601-9.
      View in: PubMed
    138. Volkow ND, Fowler JS, Wang GJ. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol. 2002 Sep; 13(5-6):355-66.
      View in: PubMed
    139. Wang GJ, Volkow ND, Felder C, Fowler JS, Levy AV, Pappas NR, Wong CT, Zhu W, Netusil N. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport. 2002 Jul 2; 13(9):1151-5.
      View in: PubMed
    140. Fowler JS, Logan J, Volkow ND, Wang GJ, MacGregor RR, Ding YS. Monoamine oxidase: radiotracer development and human studies. Methods. 2002 Jul; 27(3):263-77.
      View in: PubMed
    141. Volkow ND, Wang GJ, Fowler JS, Logan J, Jayne M, Franceschi D, Wong C, Gatley SJ, Gifford AN, Ding YS, Pappas N. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse. 2002 Jun 1; 44(3):175-80.
      View in: PubMed
    142. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse. 2002 Mar 1; 43(3):181-7.
      View in: PubMed
    143. Fowler JS, Ido T. Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med. 2002 Jan; 32(1):6-12.
      View in: PubMed
    144. Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ. Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord. 2002; 6 Suppl 1:S31-43.
      View in: PubMed
    145. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001 Dec; 158(12):2015-21.
      View in: PubMed
    146. Fowler JS, Logan J, Ding YS, Franceschi D, Wang GJ, Volkow ND, Pappas N, Schlyer D, Gatley SJ, Alexoff D, Felder C, Biegon A, Zhu W. Non-MAO A binding of clorgyline in white matter in human brain. J Neurochem. 2001 Dec; 79(5):1039-46.
      View in: PubMed
    147. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci. 2001 Dec 1; 21(23):9414-8.
      View in: PubMed
    148. Fowler JS, Ding YS, Logan J, MacGregor RR, Shea C, Garza V, Gimi R, Volkow ND, Wang GJ, Schlyer D, Ferrieri R, Gatley SJ, Alexoff D, Carter P, King P, Pappas N, Arnett CD. Species differences in [11C]clorgyline binding in brain. Nucl Med Biol. 2001 Oct; 28(7):779-85.
      View in: PubMed
    149. Goldstein RZ, Volkow ND, Wang GJ, Fowler JS, Rajaram S. Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport. 2001 Aug 8; 12(11):2595-9.
      View in: PubMed
    150. Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J. [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol. 2001 Jul; 28(5):561-72.
      View in: PubMed
    151. Fowler JS, Volkow ND. 18FDG for the study of central nervous system drugs. J Clin Pharmacol. 2001 Jul; Suppl:9S-10S.
      View in: PubMed
    152. Fowler JS, Volkow ND, Logan J, Franceschi D, Wang GJ, MacGregor R, Shea C, Garza V, Pappas N, Carter P, Netusil N, Bridge P, Liederman D, Elkashef A, Rotrosen J, Hitzemann R. Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain. Life Sci. 2001 May 4; 68(24):2759-68.
      View in: PubMed
    153. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry. 2001 Mar; 158(3):383-9.
      View in: PubMed
    154. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001 Mar; 158(3):377-82.
      View in: PubMed
    155. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab. 2001 Mar; 21(3):307-20.
      View in: PubMed
    156. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS. Brain dopamine and obesity. Lancet. 2001 Feb 3; 357(9253):354-7.
      View in: PubMed
    157. Volkow ND, Ding YS, Fowler JS, Gatley SJ. Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol Psychiatry. 2001 Feb 1; 49(3):211-20.
      View in: PubMed
    158. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001 Jan 15; 21(2):RC121.
      View in: PubMed
    159. Logan J, Fowler JS, Dewey SL, Volkow ND, Gatley SJ. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone. J Neural Transm. 2001; 108(3):279-86.
      View in: PubMed
    160. Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, Shea C, MacGregor RR, Garza V. Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. Am J Psychiatry. 2000 Nov; 157(11):1864-6.
      View in: PubMed
    161. Volkow ND, Wang GJ, Fowler JS, Rooney WD, Felder CA, Lee JH, Franceschi D, Maynard L, Schlyer DJ, Pan JW, Gatley SJ, Springer Jr CS. Resting brain metabolic activity in a 4 tesla magnetic field. Magn Reson Med. 2000 Nov; 44(5):701-5.
      View in: PubMed
    162. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley JS, Pappas NR, Wong CT, Felder C. Increased activity of the temporal insula in subjects with bradycardia. Life Sci. 2000 Sep 22; 67(18):2213-20.
      View in: PubMed
    163. Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D, Franceschi M, Logan J, Gatley SJ, Wong C, Ding YS, Hitzemann R, Pappas N. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 2000 Aug 11; 67(12):1507-15.
      View in: PubMed
    164. Wang GJ, Volkow ND, Fowler JS, Franceschi D, Logan J, Pappas NR, Wong CT, Netusil N. PET studies of the effects of aerobic exercise on human striatal dopamine release. J Nucl Med. 2000 Aug; 41(8):1352-6.
      View in: PubMed
    165. Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, Pappas N, Wong CT, Hitzemann RJ, Felder CA. Regional brain metabolism during alcohol intoxication. Alcohol Clin Exp Res. 2000 Jun; 24(6):822-9.
      View in: PubMed
    166. Ding Y, Liu N, Wang T, Marecek J, Garza V, Ojima I, Fowler JS. Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. Nucl Med Biol. 2000 May; 27(4):381-9.
      View in: PubMed
    167. Volkow ND, Gatley SJ, Fowler JS, Wang GJ, Swanson J. Serotonin and the therapeutic effects of ritalin. Science. 2000 Apr 7; 288(5463):11.
      View in: PubMed
    168. Ding YS, Logan J, Bermel R, Garza V, Rice O, Fowler JS, Volkow ND. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine. J Neurochem. 2000 Apr; 74(4):1514-21.
      View in: PubMed
    169. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000 Mar; 10(3):318-25.
      View in: PubMed
    170. Ding YS, Volkow ND, Logan J, Garza V, Pappas N, King P, Fowler JS. Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette. Synapse. 2000 Mar 1; 35(3):234-7.
      View in: PubMed
    171. Volkow ND, Wang GJ, Fowler JS, Franceschi D, Thanos PK, Wong C, Gatley SJ, Ding YS, Molina P, Schlyer D, Alexoff D, Hitzemann R, Pappas N. Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. Life Sci. 2000 Feb 11; 66(12):PL161-7.
      View in: PubMed
    172. Fowler JS, Wang GJ, Volkow ND, Logan J, Franceschi D, Franceschi M, MacGregor R, Shea C, Garza V, Liu N, Ding YS. Evidence that gingko biloba extract does not inhibit MAO A and B in living human brain. Life Sci. 2000 Jan 21; 66(9):PL141-6.
      View in: PubMed
    173. Logan J, Fowler JS, Volkow ND, Wang GJ, MacGregor RR, Shea C. Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain. Nucl Med Biol. 2000 Jan; 27(1):43-9.
      View in: PubMed
    174. Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C, Felder C, Gatley SJ, Ding YS, Hitzemann R, Pappas N. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry. 2000 Jan; 157(1):75-80.
      View in: PubMed
    175. Volkow ND, Fowler JS, Wang GJ. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol. 1999 Dec; 13(4):337-45.
      View in: PubMed
    176. Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, Shea C, MacGregor RR, Garza V. Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers. Nicotine Tob Res. 1999 Dec; 1(4):325-9.
      View in: PubMed
    177. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther. 1999 Oct; 291(1):409-15.
      View in: PubMed
    178. Firouzbakht ML, Schlyer DJ, Fowler JS. Cryogenic target design considerations for the production of [18F]fluoride from enriched [18O]carbon dioxide. Nucl Med Biol. 1999 Oct; 26(7):749-53.
      View in: PubMed
    179. Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding YS, Logan J. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl). 1999 Sep 1; 146(1):93-100.
      View in: PubMed
    180. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry. 1999 Sep; 156(9):1440-3.
      View in: PubMed
    181. Fowler JS, Volkow ND, Ding YS, Wang GJ, Dewey S, Fischman MW, Foltin R, Hitzemann R. Positron emission tomography studies of dopamine-enhancing drugs. J Clin Pharmacol. 1999 Aug; Suppl:13S-16S.
      View in: PubMed
    182. Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. J Nucl Med. 1999 Aug; 40(8):1285-91.
      View in: PubMed
    183. Sammi MK, Felder CA, Fowler JS, Lee JH, Levy AV, Li X, Logan J, Pályka I, Rooney WD, Volkow ND, Wang GJ, Springer CS. Intimate combination of low- and high-resolution image data: I. Real-space PET and (1)H(2)O MRI, PETAMRI. Magn Reson Med. 1999 Aug; 42(2):345-60.
      View in: PubMed
    184. Fowler JS, Volkow ND, Wang GJ, Ding YS, Dewey SL. PET and drug research and development. J Nucl Med. 1999 Jul; 40(7):1154-63.
      View in: PubMed
    185. Wang GJ, Volkow ND, Levy AV, Felder CA, Fowler JS, Pappas NR, Hitzemann RJ, Wong CT. Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps. J Nucl Med. 1999 May; 40(5):715-20.
      View in: PubMed
    186. Ferrieri RA, Garcia I, Fowler JS, Wolf AP. Investigations of acetonitrile solvent cluster formation in supercritical carbon dioxide, and its impact on microscale syntheses of carbon-11-labeled radiotracers for PET. Nucl Med Biol. 1999 May; 26(4):443-54.
      View in: PubMed
    187. Firouzbakht ML, Schlyer DJ, Wolf AP, Fowler JS. Mechanism of nitrogen-13-labeled ammonia formation in a cryogenic water target. Nucl Med Biol. 1999 May; 26(4):437-41.
      View in: PubMed
    188. Telang FW, Volkow ND, Levy A, Logan J, Fowler JS, Felder C, Wong C, Wang GJ. Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images. Synapse. 1999 Mar 15; 31(4):290-6.
      View in: PubMed
    189. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry. 1999 Jan; 156(1):19-26.
      View in: PubMed
    190. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Dewey SL, Hitzemann R, Gifford AN, Pappas NR. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J Pharmacol Exp Ther. 1999 Jan; 288(1):14-20.
      View in: PubMed
    191. Volkow ND, Wang GJ, Fowler JS, Fischman M, Foltin R, Abumrad NN, Gatley SJ, Logan J, Wong C, Gifford A, Ding YS, Hitzemann R, Pappas N. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci. 1999; 65(1):PL7-12.
      View in: PubMed
    192. Ding YS, Molina PE, Fowler JS, Logan J, Volkow ND, Kuhar MJ, Carroll FI. Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. Nucl Med Biol. 1999 Jan; 26(1):139-48.
      View in: PubMed
    193. Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse. 1999 Jan; 31(1):59-66.
      View in: PubMed
    194. Wang GJ, Volkow ND, Fowler JS, Cervany P, Hitzemann RJ, Pappas NR, Wong CT, Felder C. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci. 1999; 64(9):775-84.
      View in: PubMed
    195. Volkow ND, Fowler JS, Ding YS, Wang GJ, Gatley SJ. Imaging the neurochemistry of nicotine actions: studies with positron emission tomography. Nicotine Tob Res. 1999; 1 Suppl 2:S127-32; discussion S139-40.
      View in: PubMed
    196. Wang GJ, Volkow ND, Fowler JS, Pappas NR, Wong CT, Pascani K, Felder CA, Hitzemann RJ. Regional cerebral metabolism in female alcoholics of moderate severity does not differ from that of controls. Alcohol Clin Exp Res. 1998 Nov; 22(8):1850-4.
      View in: PubMed
    197. Dewey SL, Morgan AE, Ashby CR, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. A novel strategy for the treatment of cocaine addiction. Synapse. 1998 Oct; 30(2):119-29.
      View in: PubMed
    198. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry. 1998 Oct; 155(10):1325-31.
      View in: PubMed
    199. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley J, Ding YS, Wong C, Pappas N. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Psychiatry Res. 1998 Jul 15; 83(1):29-36.
      View in: PubMed
    200. Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, Logan J, Moberg PJ, Hitzemann R, Smith G, Pappas N. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging. Ann Neurol. 1998 Jul; 44(1):143-7.
      View in: PubMed
    201. Gatley SJ, Ding YS, Brady D, Gifford AN, Dewey SL, Carroll FI, Fowler JS, Volkow ND. In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronochloroepibatidine in rodent and human brain. Nucl Med Biol. 1998 Jul; 25(5):449-54.
      View in: PubMed
    202. Wang GJ, Volkow ND, Fowler JS, Hitzemann RJ, Pappas NR, Netusil N. Evaluation of gender difference in regional brain metabolic responses to lorazepam. Psychiatry Res. 1998 Apr 10; 82(1):37-46.
      View in: PubMed
    203. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, Hitzemann R, Smith G, Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry. 1998 Mar; 155(3):344-9.
      View in: PubMed
    204. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Gatley SJ, Dewey SS, Pappas N. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Am J Psychiatry. 1998 Feb; 155(2):200-6.
      View in: PubMed
    205. Fowler JS, Volkow ND, Logan J, Gatley SJ, Pappas N, King P, Ding YS, Wang GJ. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations. Synapse. 1998 Feb; 28(2):111-6.
      View in: PubMed
    206. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. J Addict Dis. 1998; 17(1):23-34.
      View in: PubMed
    207. Ding YS, Logan J, Gatley SJ, Fowler JS, Volkow ND. PET studies of peripheral catechol-O-methyltransferase in non-human primates using [18F]Ro41-0960. J Neural Transm. 1998; 105(10-12):1199-211.
      View in: PubMed
    208. Fowler JS, Volkow ND, Wang GJ, Pappas N, Shea C, MacGregor RR, Logan J. Visualization of monoamine oxidase in human brain. Adv Pharmacol. 1998; 42:304-7.
      View in: PubMed
    209. Schlösser R, Brodie JD, Dewey SL, Alexoff D, Wang GJ, Fowler JS, Volkow N, Logan J, Wolf AP. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET. Synapse. 1998 Jan; 28(1):66-70.
      View in: PubMed
    210. Fowler JS, Volkow ND. PET imaging studies in drug abuse. J Toxicol Clin Toxicol. 1998; 36(3):163-74.
      View in: PubMed
    211. Fowler JS, Volkow ND, Logan J, Pappas N, King P, MacGregor R, Shea C, Garza V, Gatley SJ. An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. Life Sci. 1998; 63(2):PL19-23.
      View in: PubMed
    212. Volkow ND, Fowler JS, Ding YS, Wang GJ, Gatley SJ. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates. Adv Pharmacol. 1998; 42:211-4.
      View in: PubMed
    213. Logan J, Volkow ND, Fowler JS, Wang GJ, Fischman MW, Foltin RW, Abumrad NN, Vitkun S, Gatley SJ, Pappas N, Hitzemann R, Shea CE. Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse. 1997 Dec; 27(4):347-56.
      View in: PubMed
    214. Molina PE, Ding YS, Carroll FI, Liang F, Volkow ND, Pappas N, Kuhar M, Abumrad N, Gatley SJ, Fowler JS. Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. Nucl Med Biol. 1997 Nov; 24(8):743-7.
      View in: PubMed
    215. Volkow ND, Wang GJ, Overall JE, Hitzemann R, Fowler JS, Pappas N, Frecska E, Piscani K. Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. Alcohol Clin Exp Res. 1997 Oct; 21(7):1278-84.
      View in: PubMed
    216. Morgan AE, Porter SP, Clarkson FA, Volkow ND, Fowler JS, Dewey SL. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter. Synapse. 1997 Aug; 26(4):423-7.
      View in: PubMed
    217. Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, MacGregor R. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging. 1997 Jul-Aug; 18(4):431-5.
      View in: PubMed
    218. Volkow ND, Wang GJ, Fowler JS. Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann N Y Acad Sci. 1997 May 30; 820:41-54; discussion 54-5.
      View in: PubMed
    219. Ding YS, Fowler JS, Volkow ND, Dewey SL, Wang GJ, Logan J, Gatley SJ, Pappas N. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain. Psychopharmacology (Berl). 1997 May; 131(1):71-8.
      View in: PubMed
    220. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997 Apr 24; 386(6627):827-30.
      View in: PubMed
    221. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997 Apr 24; 386(6627):830-3.
      View in: PubMed
    222. Dewey SL, Chaurasia CS, Chen CE, Volkow ND, Clarkson FA, Porter SP, Straughter-Moore RM, Alexoff DL, Tedeschi D, Russo NB, Fowler JS, Brodie JD. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse. 1997 Apr; 25(4):393-8.
      View in: PubMed
    223. Wang GJ, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann RJ, Pappas NS, Pascani K. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology. 1997 Feb; 16(2):174-82.
      View in: PubMed
    224. Shiue CY, Vallabhahosula S, Wolf AP, Dewey SL, Fowler JS, Schlyer DJ, Arnett CD, Zhou YG. Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. Nucl Med Biol. 1997 Feb; 24(2):145-50.
      View in: PubMed
    225. Wang GJ, Volkow ND, Fowler JS, Fischman M, Foltin R, Abumrad NN, Logan J, Pappas NR. Cocaine abusers do not show loss of dopamine transporters with age. Life Sci. 1997; 61(11):1059-65.
      View in: PubMed
    226. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry. 1997 Jan; 154(1):50-5.
      View in: PubMed
    227. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Pappas N, Pascani K, Wong C. Gender differences in cerebellar metabolism: test-retest reproducibility. Am J Psychiatry. 1997 Jan; 154(1):119-21.
      View in: PubMed
    228. Volkow ND, Gatley SJ, Fowler JS, Logan J, Fischman M, Gifford AN, Pappas N, King P, Vitkun S, Ding YS, Wang GJ. Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse. 1996 Dec; 24(4):399-402.
      View in: PubMed
    229. Ding YS, Gatley SJ, Fowler JS, Volkow ND, Aggarwal D, Logan J, Dewey SL, Liang F, Carroll FI, Kuhar MJ. Mapping nicotinic acetylcholine receptors with PET. Synapse. 1996 Dec; 24(4):403-7.
      View in: PubMed
    230. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res. 1996 Dec; 20(9):1594-8.
      View in: PubMed
    231. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A. 1996 Nov 26; 93(24):14065-9.
      View in: PubMed
    232. Wang GJ, Volkow ND, Overall J, Hitzemann RJ, Pappas N, Pascani K, Fowler JS. Reproducibility of regional brain metabolic responses to lorazepam. J Nucl Med. 1996 Oct; 37(10):1609-13.
      View in: PubMed
    233. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, Dewey SL, Hitzemann R, Lieberman J. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci U S A. 1996 Sep 17; 93(19):10388-92.
      View in: PubMed
    234. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996 Sep; 16(5):834-40.
      View in: PubMed
    235. Wang GJ, Volkow ND, Lau YH, Fowler JS, Meek AG, Park TL, Wong C, Roque CT, Adler AJ, Wolf AP. Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study. J Comput Assist Tomogr. 1996 Sep-Oct; 20(5):709-14.
      View in: PubMed
    236. Fowler JS, Fazzini E, Volkow ND. Deprenyl and levodopa and Parkinson's disease progression. Ann Neurol. 1996 Aug; 40(2):267-8.
      View in: PubMed
    237. Volkow ND, Fowler JS, Gatley SJ, Logan J, Wang GJ, Ding YS, Dewey S. PET evaluation of the dopamine system of the human brain. J Nucl Med. 1996 Jul; 37(7):1242-56.
      View in: PubMed
    238. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Schlyer DJ, Hitzemann R, Wolf AP. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res. 1996 May 31; 67(1):11-6.
      View in: PubMed
    239. Wang GJ, Volkow ND, Levy AV, Fowler JS, Logan J, Alexoff D, Hitzemann RJ, Schyler DJ. MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. J Comput Assist Tomogr. 1996 May-Jun; 20(3):423-8.
      View in: PubMed
    240. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Hitzemann R, Smith G, Fields SD, Gur R. Dopamine transporters decrease with age. J Nucl Med. 1996 Apr; 37(4):554-9.
      View in: PubMed
    241. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemannn R, Gatley SJ, MacGregor RR, Wolf AP. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology. 1996 Mar; 14(3):159-68.
      View in: PubMed
    242. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996 Feb 22; 379(6567):733-6.
      View in: PubMed
    243. Gatley SJ, Volkow ND, Chen R, Fowler JS, Carroll FI, Kuhar MJ. Displacement of RTI-55 from the dopamine transporter by cocaine. Eur J Pharmacol. 1996 Jan 25; 296(2):145-51.
      View in: PubMed
    244. Volkow ND, Fowler JS, Hitzemann R, Wang GJ. Neurochemical mechanisms underlying responses to psychostimulants. NIDA Res Monogr. 1996; 159:322-48.
      View in: PubMed
    245. Volkow ND, Fowler JS, Ding YS. Cardiotoxic properties of cocaine: studies with positron emission tomography. NIDA Res Monogr. 1996; 163:159-74.
      View in: PubMed
    246. Volkow ND, Ding YS, Fowler JS, Wang GJ. Cocaine addiction: hypothesis derived from imaging studies with PET. J Addict Dis. 1996; 15(4):55-71.
      View in: PubMed
    247. Wang GJ, Volkow ND, Fowler JS, Logan J, Gur R, Netusil N, Hitzemann RJ, Pappas NS. Age associated decrements in dopamine D2 receptors in thalamus and in temporal insula of human subjects. Life Sci. 1996; 59(1):PL31-5.
      View in: PubMed
    248. Yousef KA, Fowler JS, Volkow ND, Dewey SL, Shea C, Schlyer DJ, Gatley SJ, Logan J, Wolf AP. [18F]haloperidol binding in baboon brain in vivo. Nucl Med Biol. 1996 Jan; 23(1):47-52.
      View in: PubMed
    249. Volkow ND, Wang GJ, Gatley SJ, Fowler JS, Ding YS, Logan J, Hitzemann R, Angrist B, Lieberman J. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology (Berl). 1996 Jan; 123(1):26-33.
      View in: PubMed
    250. Ding YS, Gatley SJ, Fowler JS, Chen R, Volkow ND, Logan J, Shea CE, Sugano Y, Koomen J. Mapping catechol-O-methyltransferase in vivo: initial studies with [18F]Ro41-0960. Life Sci. 1996; 58(3):195-208.
      View in: PubMed
    251. Ding YS, Fowler JS, Volkow ND, Logan J, Gatley SJ, Sugano Y. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. J Nucl Med. 1995 Dec; 36(12):2298-305.
      View in: PubMed
    252. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, Schlyer DJ, Pappas N. A new PET ligand for the dopamine transporter: studies in the human brain. J Nucl Med. 1995 Dec; 36(12):2162-8.
      View in: PubMed
    253. Alexoff DL, Shea C, Fowler JS, King P, Gatley SJ, Schlyer DJ, Wolf AP. Plasma input function determination for PET using a commercial laboratory robot. Nucl Med Biol. 1995 Oct; 22(7):893-904.
      View in: PubMed
    254. Gatley SJ, Ding YS, Volkow ND, Chen R, Sugano Y, Fowler JS. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Eur J Pharmacol. 1995 Aug 4; 281(2):141-9.
      View in: PubMed
    255. Ding YS, Fowler JS, Gatley SJ, Logan J, Volkow ND, Shea C. Mechanistic positron emission tomography studies of 6-[18F]fluorodopamine in living baboon heart: selective imaging and control of radiotracer metabolism using the deuterium isotope effect. J Neurochem. 1995 Aug; 65(2):682-90.
      View in: PubMed
    256. Fowler JS, Wang GJ, Logan J, Xie S, Volkow ND, MacGregor RR, Schlyer DJ, Pappas N, Alexoff DL, Patlak C, et al. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. J Nucl Med. 1995 Jul; 36(7):1255-62.
      View in: PubMed
    257. Volkow ND, Fowler JS, Logan J, Gatley SJ, Dewey SL, MacGregor RR, Schlyer DJ, Pappas N, King P, wang GJ, et al. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study. J Nucl Med. 1995 Jul; 36(7):1289-97.
      View in: PubMed
    258. Gatley SJ, Volkow ND, Fowler JS, Dewey SL, Logan J. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine. Synapse. 1995 Jun; 20(2):137-44.
      View in: PubMed
    259. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995 Jun; 52(6):456-63.
      View in: PubMed
    260. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Pappas N, Lowrimore P, Burr G, Pascani K, Overall J, Wolf AP. Depression of thalamic metabolism by lorazepam is associated with sleepiness. Neuropsychopharmacology. 1995 Apr; 12(2):123-32.
      View in: PubMed
    261. Volkow ND, Wang GJ, Begleiter H, Hitzemann R, Pappas N, Burr G, Pascani K, Wong C, Fowler JS, Wolf AP. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Clin Exp Res. 1995 Apr; 19(2):510-6.
      View in: PubMed
    262. Wang GJ, Volkow ND, Logan J, Fowler JS, Schlyer D, MacGregor RR, Hitzemann RJ, Gjedde A, Wolf AP. Serotonin 5-HT2 receptor availability in chronic cocaine abusers. Life Sci. 1995 Mar 10; 56(16):PL299-303.
      View in: PubMed
    263. Volkow ND, Gatley SJ, Fowler JS, Chen R, Logan J, Dewey SL, Ding YS, Pappas N, King P, MacGregor RR, et al. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT. Synapse. 1995 Mar; 19(3):206-11.
      View in: PubMed
    264. Wolf AP, Fowler JS. Positron emission tomography. Biomedical research and clinical application. Neuroimaging Clin N Am. 1995 Feb; 5(1):87-101.
      View in: PubMed
    265. Yousef KA, Volkow ND, Schlyer DJ, Fowler JS, Wolf AP, Wang GJ, Smith MR, Brodie JD, Warner D. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients. Synapse. 1995 Jan; 19(1):14-7.
      View in: PubMed
    266. Wang GJ, Volkow ND, Logan J, Fowler JS, Schlyer D, MacGregor RR, Hitzemann RJ, Gur RC, Wolf AP. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sci. 1995; 56(14):PL249-53.
      View in: PubMed
    267. Wang GJ, Volkow ND, Fowler JS, Ding YS, Logan J, Gatley SJ, MacGregor RR, Wolf AP. Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain. Life Sci. 1995; 57(14):PL187-91.
      View in: PubMed
    268. Logan J, Volkow ND, Fowler JS, Wang GJ, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P, et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994 Nov; 14(6):995-1010.
      View in: PubMed
    269. Pan D, Gatley SJ, Dewey SL, Chen R, Alexoff DA, Ding YS, Fowler JS. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur J Pharmacol. 1994 Oct 24; 264(2):177-82.
      View in: PubMed
    270. Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schyler D, Wolf AP, Pappas N, Alexoff D, Shea C, et al. Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse. 1994 Oct; 18(2):86-93.
      View in: PubMed
    271. Ding YS, Fowler JS, Volkow ND, Gatley SJ, Logan J, Dewey SL, Alexoff D, Fazzini E, Wolf AP. Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse. 1994 Oct; 18(2):152-60.
      View in: PubMed
    272. Volkow ND, Fowler JS, Wang GJ, Logan J, Schlyer D, MacGregor R, Hitzemann R, Wolf AP. Decreased dopamine transporters with age in health human subjects. Ann Neurol. 1994 Aug; 36(2):237-9.
      View in: PubMed
    273. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, et al. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry. 1994 May; 151(5):681-6.
      View in: PubMed
    274. Fowler JS, Ding YS, Volkow ND, Martin T, MacGregor RR, Dewey S, King P, Pappas N, Alexoff D, Shea C, et al. PET studies of cocaine inhibition of myocardial norepinephrine uptake. Synapse. 1994 Apr; 16(4):312-7.
      View in: PubMed
    275. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, et al. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse. 1994 Apr; 16(4):255-62.
      View in: PubMed
    276. Gatley SJ, Yu DW, Fowler JS, MacGregor RR, Schlyer DJ, Dewey SL, Wolf AP, Martin T, Shea CE, Volkow ND. Studies with differentially labeled [11C]cocaine, [11C]norcocaine, [11C]benzoylecgonine, and [11C]- and 4'-[18F]fluorococaine to probe the extent to which [11C]cocaine metabolites contribute to PET images of the baboon brain. J Neurochem. 1994 Mar; 62(3):1154-62.
      View in: PubMed
    277. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Overall JE, Burr G, Wolf AP. Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry. 1994 Feb; 151(2):178-83.
      View in: PubMed
    278. Wang GJ, Volkow ND, Wolf AP, Madajewicz S, Fowler JS, Schlyer DJ, MacGregor RR. Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine. Nucl Med Biol. 1994 Jan; 21(1):77-82.
      View in: PubMed
    279. Volkow ND, Fowler JS. Brain-imaging studies of the combined use of cocaine and alcohol and of the pharmacokinetics of cocaethylene. NIDA Res Monogr. 1994; 138:41-56.
      View in: PubMed
    280. Wang GJ, Volkow ND, Fowler JS, Ferrieri R, Schlyer DJ, Alexoff D, Pappas N, Lieberman J, King P, Warner D, et al. Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci. 1994; 54(9):PL143-6.
      View in: PubMed
    281. Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):11816-20.
      View in: PubMed
    282. Wang GJ, Volkow ND, Fowler JS, Wolf AP, MacGregor RR, Shea CE, Schlyer DJ, Hitzemann RJ. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain. Synapse. 1993 Nov; 15(3):246-9.
      View in: PubMed
    283. Fowler JS, Volkow ND, Logan J, Schlyer DJ, MacGregor RR, Wang GJ, Wolf AP, Pappas N, Alexoff D, Shea C, et al. Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327. Neurology. 1993 Oct; 43(10):1984-92.
      View in: PubMed
    284. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993 Jun; 14(2):169-77.
      View in: PubMed
    285. Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, et al. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med. 1993 Apr; 34(4):609-13.
      View in: PubMed
    286. Dewey SL, Smith GS, Logan J, Brodie JD, Fowler JS, Wolf AP. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse. 1993 Apr; 13(4):350-6.
      View in: PubMed
    287. Ding YS, Fowler JS, Dewey SL, Logan J, Schlyer DJ, Gatley SJ, Volkow ND, King PT, Wolf AP. Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J Nucl Med. 1993 Apr; 34(4):619-29.
      View in: PubMed
    288. Ferrieri RA, Schlyer DJ, Alexoff DL, Fowler JS, Wolf AP. Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector. Nucl Med Biol. 1993 Apr; 20(3):367-9.
      View in: PubMed
    289. Gatley SJ, Ferrieri RA, Fowler JS, MacGregor RR, Wolf AP. Rapid radiochemical and chemical quality control of [11C]putrescine. Appl Radiat Isot. 1993 Apr; 44(4):765-7.
      View in: PubMed
    290. Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL. Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry. 1993 Mar; 150(3):417-22.
      View in: PubMed
    291. Ding YS, Fowler JS, Dewey SL, Wolf AP, Logan J, Gatley SJ, Volkow ND, Shea C, Taylor DP. Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug. J Nucl Med. 1993 Feb; 34(2):246-54.
      View in: PubMed
    292. Fowler JS, Volkow ND, Logan J, MacGregor RR, Wang GJ, Wolf AP. Alcohol intoxication does not change [11C]cocaine pharmacokinetics in human brain and heart. Synapse. 1992 Nov; 12(3):228-35.
      View in: PubMed
    293. Fowler JS, Volkow ND, MacGregor RR, Logan J, Dewey SL, Gatley SJ, Wolf AP. Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain. Synapse. 1992 Nov; 12(3):220-7.
      View in: PubMed
    294. Alexoff DL, Casati R, Fowler JS, Wolf AP, Shea C, Schlyer DJ, Shiue CY. Ion chromatographic analysis of high specific activity 18FDG preparations and detection of the chemical impurity 2-deoxy-2-chloro-D-glucose. Int J Rad Appl Instrum A. 1992 Nov; 43(11):1313-22.
      View in: PubMed
    295. Volkow ND, Fowler JS. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse. Semin Nucl Med. 1992 Oct; 22(4):254-67.
      View in: PubMed
    296. Fowler JS, Wolf AP, Volkow ND, Brodie JD, Hiesiger E. The value of "the putrescine experience". J Nucl Med. 1992 Sep; 33(9):1720-1.
      View in: PubMed
    297. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Burr G, Pascani K, Dewey SL, Wolf AP. Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry. 1992 Aug; 149(8):1016-22.
      View in: PubMed
    298. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse. 1992 Jul; 11(3):184-90.
      View in: PubMed
    299. Yu DW, Gatley SJ, Wolf AP, MacGregor RR, Dewey SL, Fowler JS, Schlyer DJ. Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. J Med Chem. 1992 Jun 12; 35(12):2178-83.
      View in: PubMed
    300. Schlyer DJ, Volkow ND, Fowler JS, Wolf AP, Shiue CY, Dewey SL, Bendriem B, Logan J, Raulli R, Hitzemann R, et al. Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol. Synapse. 1992 May; 11(1):10-9.
      View in: PubMed
    301. Volkow ND, Fowler JS, Wolf AP, Wang GJ, Logan J, MacGregor R, Dewey SL, Schlyer D, Hitzemann R. Distribution and kinetics of carbon-11-cocaine in the human body measured with PET. J Nucl Med. 1992 Apr; 33(4):521-5.
      View in: PubMed
    302. Biegon A, Dillon K, Volkow ND, Hitzemann RJ, Fowler JS, Wolf AP. Quantitative autoradiography of cocaine binding sites in human brain postmortem. Synapse. 1992 Feb; 10(2):126-30.
      View in: PubMed
    303. MacGregor RR, Fowler JS, Wolf AP. Determination of the enantiomeric composition of samples of cocaine by normal-phase high-performance liquid chromatography with UV detection. J Chromatogr. 1992 Jan 31; 590(2):354-8.
      View in: PubMed
    304. Logan J, Dewey SL, Wolf AP, Fowler JS, Brodie JD, Angrist B, Volkow ND, Gatley SJ. Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons. Synapse. 1991 Nov; 9(3):195-207.
      View in: PubMed
    305. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991 May; 148(5):621-6.
      View in: PubMed
    306. Dewey SL, Logan J, Wolf AP, Brodie JD, Angrist B, Fowler JS, Volkow ND. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse. 1991 Apr; 7(4):324-7.
      View in: PubMed
    307. Ding YS, Fowler JS, Gatley SJ, Dewey SL, Wolf AP, Schlyer DJ. Synthesis of high specific activity 6-[18F]fluorodopamine for positron emission tomography studies of sympathetic nervous tissue. J Med Chem. 1991 Feb; 34(2):861-3.
      View in: PubMed
    308. Ding YS, Fowler JS, Gatley SJ, Dewey SL, Wolf AP. Synthesis of high specific activity (+)- and (-)-6-[18F]fluoronorepinephrine via the nucleophilic aromatic substitution reaction. J Med Chem. 1991 Feb; 34(2):767-71.
      View in: PubMed
    309. Shiue CY, Bai LQ, Teng RR, Arnett CD, Dewey SL, Wolf AP, McPherson DW, Fowler JS, Logan J, Holland MJ, et al. A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET. Int J Rad Appl Instrum B. 1991; 18(3):281-8.
      View in: PubMed
    310. Volkow ND, Fowler JS, Wolf AP. Use of positron emission tomography to study cocaine in the human brain. NIDA Res Monogr. 1991; 112:168-79.
      View in: PubMed
    311. Alexoff DL, Fowler JS, Gatley SJ. Removal of the 2.2.2 cryptand (Kryptofix 2.2.2) from 18FDG by cation exchange. Int J Rad Appl Instrum A. 1991; 42(12):1189-93.
      View in: PubMed
    312. Fowler JS, Wolf AP. New developments in radiotracers for positron emission tomography. NIDA Res Monogr. 1991; 112:146-67.
      View in: PubMed
    313. Dewey SL, Volkow ND, Logan J, MacGregor RR, Fowler JS, Schlyer DJ, Bendriem B. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res. 1990 Dec; 27(4):569-75.
      View in: PubMed
    314. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990 Sep; 10(5):740-7.
      View in: PubMed
    315. Plenevaux A, Dewey SL, Fowler JS, Guillaume M, Wolf AP. Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain. J Med Chem. 1990 Jul; 33(7):2015-9.
      View in: PubMed
    316. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue CY, Alpert R, Dewey SL, Logan J, Bendriem B, Christman D, et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry. 1990 Jun; 147(6):719-24.
      View in: PubMed
    317. Volkow ND, Hitzemann R, Wolf AP, Logan J, Fowler JS, Christman D, Dewey SL, Schlyer D, Burr G, Vitkun S, et al. Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Res. 1990 Apr; 35(1):39-48.
      View in: PubMed
    318. Gatley SJ, MacGregor RR, Fowler JS, Wolf AP, Dewey SL, Schlyer DJ. Rapid stereoselective hydrolysis of (+)-cocaine in baboon plasma prevents its uptake in the brain: implications for behavioral studies. J Neurochem. 1990 Feb; 54(2):720-3.
      View in: PubMed
    319. Volkow ND, Fowler JS, Wolf AP, Gillespi H. Metabolic studies of drugs of abuse. NIDA Res Monogr. 1990; 105:47-53.
      View in: PubMed
    320. Dewey SL, Brodie JD, Fowler JS, MacGregor RR, Schlyer DJ, King PT, Alexoff DL, Volkow ND, Shiue CY, Wolf AP, et al. Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain. Synapse. 1990; 6(4):321-7.
      View in: PubMed
    321. Fowler JS, Wolf AP. The heritage of radiotracers for positron emission tomography. Acta Radiol Suppl. 1990; 374:13-6.
      View in: PubMed
    322. Dewey SL, MacGregor RR, Brodie JD, Bendriem B, King PT, Volkow ND, Schlyer DJ, Fowler JS, Wolf AP, Gatley SJ, et al. Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. Synapse. 1990; 5(3):213-23.
      View in: PubMed
    323. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, Macgregor RR, Hitzemann R, Logan J, Bendriem B, Gatley SJ, et al. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse. 1989; 4(4):371-7.
      View in: PubMed
    324. Fowler JS, Wolf AP, MacGregor RR, Dewey SL, Logan J, Schlyer DJ, Langstrom B. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain. J Neurochem. 1988 Nov; 51(5):1524-34.
      View in: PubMed
    325. Hiesiger E, Fowler JS, Wolf AP, Logan J, Brodie JD, McPherson D, MacGregor RR, Christman DR, Volkow ND, Flamm E. Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose. J Nucl Med. 1987 Aug; 28(8):1251-61.
      View in: PubMed
    326. McPherson DW, Fowler JS, Wolf AP, Arnett CD, Brodie JD, Volkow N. Synthesis and biodistribution of no-carrier-added [1-11C]putrescine. J Nucl Med. 1985 Oct; 26(10):1186-9.
      View in: PubMed
    327. Brodie JD, Christman DR, Corona JF, Fowler JS, Gomez-Mont F, Jaeger J, Micheels PA, Rotrosen J, Russell JA, Volkow ND, et al. Patterns of metabolic activity in the treatment of schizophrenia. Ann Neurol. 1984; 15 Suppl:S166-9.
      View in: PubMed
    Fowler's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067